Ironwood Pharmaceuticals, Inc. (IRWD) has a consensus analyst rating of Hold, based on 30 analysts covering the stock. Of those, 11 recommend buying, 16 recommend holding, and 3 recommend selling.
The analyst consensus price target for IRWD is $4.80, representing a +18.8% upside from the current price of $4.04. Price targets range from a low of $3.70 to a high of $5.70.
